Logo image of AKH.OL

AKER HORIZONS ASA (AKH.OL) Stock Fundamental Analysis

OSL:AKH - Euronext Oslo - NO0010921232 - Common Stock - Currency: NOK

1.465  +0.05 (+3.46%)

Fundamental Rating

1

AKH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 44 industry peers in the Commercial Services & Supplies industry. The financial health of AKH is average, but there are quite some concerns on its profitability. AKH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AKH has reported negative net income.
AKH had negative earnings in each of the past 5 years.
AKH had a negative operating cash flow in each of the past 5 years.
AKH.OL Yearly Net Income VS EBIT VS OCF VS FCFAKH.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2B -4B -6B

1.2 Ratios

With a Return On Assets value of -0.87%, AKH perfoms like the industry average, outperforming 41.30% of the companies in the same industry.
AKH has a Return On Equity (-7.36%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.87%
ROE -7.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKH.OL Yearly ROA, ROE, ROICAKH.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

AKH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AKH.OL Yearly Profit, Operating, Gross MarginsAKH.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

4

2. Health

2.1 Basic Checks

AKH does not have a ROIC to compare to the WACC, probably because it is not profitable.
AKH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AKH.OL Yearly Shares OutstandingAKH.OL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 200M 400M 600M
AKH.OL Yearly Total Debt VS Total AssetsAKH.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

AKH has an Altman-Z score of 0.55. This is a bad value and indicates that AKH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.55, AKH is doing worse than 69.57% of the companies in the same industry.
AKH has a Debt/Equity ratio of 5.21. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AKH (5.21) is worse than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACCN/A
WACC3.53%
AKH.OL Yearly LT Debt VS Equity VS FCFAKH.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5B -5B 10B 15B

2.3 Liquidity

A Current Ratio of 10.50 indicates that AKH has no problem at all paying its short term obligations.
AKH has a Current ratio of 10.50. This is amongst the best in the industry. AKH outperforms 97.83% of its industry peers.
AKH has a Quick Ratio of 9.70. This indicates that AKH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 9.70, AKH belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.5
Quick Ratio 9.7
AKH.OL Yearly Current Assets VS Current LiabilitesAKH.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2B 4B 6B 8B 10B

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.88% over the past year.
The Revenue for AKH has decreased by -82.46% in the past year. This is quite bad
Measured over the past years, AKH shows a very negative growth in Revenue. The Revenue has been decreasing by -13.27% on average per year.
EPS 1Y (TTM)93.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.42%
Revenue 1Y (TTM)-82.46%
Revenue growth 3Y-13.27%
Revenue growth 5YN/A
Sales Q2Q%-67.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AKH.OL Yearly Revenue VS EstimatesAKH.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1B 2B 3B
AKH.OL Yearly EPS VS EstimatesAKH.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKH.OL Price Earnings VS Forward Price EarningsAKH.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKH.OL Per share dataAKH.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AKH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKER HORIZONS ASA

OSL:AKH (3/7/2025, 7:00:00 PM)

1.465

+0.05 (+3.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-13 2025-02-13
Earnings (Next)05-08 2025-05-08
Inst Owners3.81%
Inst Owner ChangeN/A
Ins Owners1.06%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts75
Price Target10.81 (637.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-29.33%
PT rev (3m)-0.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.58
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.93
BVpS5.43
TBVpS2.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.87%
ROE -7.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.5
Quick Ratio 9.7
Altman-Z 0.55
F-ScoreN/A
WACC3.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-82.46%
Revenue growth 3Y-13.27%
Revenue growth 5YN/A
Sales Q2Q%-67.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y91.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A